Available online on 15.08.2025 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2025 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article                                                                            Review Article

Morin: A Powerful Potential Flavonoid for Human

Sampda Jain *, Yogesh Yadav , Manoj Sharma 

School of Studies in Pharmaceutical Sciences, Jiwaji University Gwalior (Madhya Pradesh), India, 474001

Article Info:

_________________________________________________

Article History:

Received 19 May 2025  

Reviewed 29 June 2025  

Accepted 27 July 2025  

Published 15 August 2025  

_________________________________________________

Cite this article as: 

Jain S, Yadav Y, Sharma M, Morin: A Powerful Potential Flavonoid for Human, Journal of Drug Delivery and Therapeutics. 2025; 15(8):237-241 DOI: http://dx.doi.org/10.22270/jddt.v15i8.7269                                  _________________________________________________

*For Correspondence:  

Sampda Jain, School of Studies in Pharmaceutical Sciences, Jiwaji University Gwalior (Madhya Pradesh), India, 474001

Abstract

____________________________________________________________________________________________________________

Objective: A bioflavonoid obtained from plants in the Moraceae family, morin exhibits strong pharmacological potential because of its hepatoprotective, neuroprotective, cardioprotective, anti-inflammatory, antioxidant, and anticancer effects. It is a promising therapeutic agent for diseases like diabetes, cancer, and neurodegenerative disorders because of its low toxicity and capacity to alter important cellular signaling pathways like Nrf2/HO-1 and EGFR.

Data Sources: Its antioxidant mechanism effectively reduces oxygen species that are reactive and oxidative damage through the Nrf2/HO-1 pathway, potentially preventing neurodegenerative diseases.

Study Selection: The effectiveness of morin has been proven in both Parkinson's disease and colitis models, highlighting its neuroprotective and anti-inflammatory properties, anti-oxidant, cardioprotective, anti-diabetic, synergistic effects. Morin's anti-inflammatory properties, whereby it reduces glial activation and improves tissue recovery.

Summary of Contents of the Article: Morin acts as a non-competitive inhibitor of PTP1B in anti-diabetic studies, thereby enhancing insulin sensitivity. Its anti-cancer effects consist in increasing death by caspase activation and blocking of metastases in breast cancer. Morin also guards against liver damage, neurotoxicity, and myocardial ischemia-reperfusion injury.

Conclusion: Although morin has low toxicity and great tolerance, the exact molecular mechanisms of it are yet unknown and demand more in vitro and in vivo research. Establishing safe dosage, efficacy, and dose-response relationships requires clinical trials, which also help to open the path for morin's inclusion into dietary supplements and drug development for chronic diseases.

Keywords: Caspase activation, Flavonoid, Hepatoprotective, Morin, Reactive oxygen species.

 


 

INTRODUCTION

Pharmacological research has become more interested in natural compounds like flavonoids because of their low cost, widespread availability, and lack of side effects. The potent anti-inflammatory, anti-apoptotic, and other pharmacological characteristics of morin, a key bioflavonol, making it one of the most important bioflavonoids, particularly in the treatment of chronic diseases. 1

Numerous health benefits have been demonstrated for morin, a naturally found polyphenol that is extracted from a variety of plants. It has anti-inflammatory, antihypertensive, anti-tumoral, antibacterial, neuroprotective, hypouricemic, antidiabetic, and antioxidant qualities by changing the activity of enzymes. Additionally, morin is well tolerated across time and has low toxicity, which suggests that it may be able to prevent a number of diseases2. Plant bioflavonoid morin hydrate has anti-inflammatory, anti-cancer, and anti-microbial qualities, among other health advantages. In addition to being a dietary supplement for better health and drug development, it also modifies cellular signaling pathways. However, to assure safety and dose-response interactions, specific clinical trials are required 3The morphology, kinetic, thermochemical, and electronic features of morin flavonoid in order to learn about its molecular features and its greatest radical scavenging activity. Morin showed the highest radical scavenging activity under excess free radical. The structural organization is in accordance with the 3-O semiquinone. The predominant reactive sites were 3-OH, 2′-OH, and 4′-OH, and the first product was 3-O–2′-O quinone. Mendoza. 4 Morin has potent pharmacological effects against various cancers and has been studied as a natural dietary supplement to enhance the effects of other anticancer drugs 5

MORIN

Morin is a yellow, crystalline flavonoid mainly in Moreasece family plants 


 

 

 

PROPERTIES OF MORIN

Table 1: Properties of morin 6

IUPAC Name

2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one

Molecular formula

C15H10O7

Molecular Weight

302.23 g/mol

 Physical properties

Solid

 Melting Point

303 - 304 °C

 

MORIN HYDRATE CHEMISTRY

Morin's molecular formula is C15H10O7, and 2-(2,4-dihydroxyphenyl)- 3,5,7-trihydroxychromen-4-one is its IUPAC. Three additional hydroxy substituents are present at positions 2', 4', and 5 of the pentahydroxy flavone morin. The weight of the molecule is 302.23 g/mol. 6

 image

Figure 1: Chemical structure of morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one)

PHARMACOLOGICAL ACTIVITY

Morin contains pharmacological characteristics such as anti-inflammatory and anti-apoptotic, shows promise for treating these conditions. This chapter reviews available research on morin’s molecular mechanisms and its potential as a therapeutic agent.7 By reducing reactive oxygen species (ROS) and blocking several targets, the bioflavonoid morin, which is well-known for its antioxidant qualities, has been acknowledged for its potential in both preventing and treating these conditions. It is anticipated that neurodegenerative diseases will overtake all other causes of death worldwide, placing a heavy financial strain on families and healthcare systems. Despite the lack of disease-modifying treatment strategies, oxidative stress is a key factor in many neurodegenerative disorders 8

Anti-Inflammatory Activity: Morin showed anti-inflammatory properties during the acute stage of rat colitis caused by trinitrobenzene sulfonic acid. It facilitated tissue recovery, reduced myeloperoxidase activity, and enhanced oxidative stress in the colon, inhibiting the activity of colonic nitric oxide synthase. 9 

Anti- oxidant activity: The study investigates the antioxidant properties of flavonoids, specifically morin, from Moraceae plants. Morin showed strong scavenging effects against ABTS•+ radicals and reduced reactive oxygen species production and nuclear DNA damage caused by H2O2. It also restored cell viability by inhibiting mitochondrial dysfunction-mediated apoptosis. Morin also activated the Nrf2/HO-1 pathway and increased the expression of heme oxygenase-1, which is essential for reducing the harm that oxidative stress does to DNA. 10 Morin, when pre-treated with ISO, decreased lipid hydroperoxide, Catalase, glutathione peroxidase, superoxide dismutase, and reactive substances induced by thiobarbituric acid, and non -enzymatic antioxidants in rats, according to the study. 11

Anti-diabetic activity: Type-2 diabetes is an insulin resistant disease with PTP1B as the chief negative regulator. Inhibiting or downregulating this enzyme enhances insulin sensitivity, making it a target for developing innovative anti-diabetic drugs. A research’s found Morin to be a novel non-competitive small molecular the inhibitor of PTP1B, that functions as activator and sensitizer for insulin receptors, activating only metabolic pathways. Morin's cell action was tested on HepG2 cells and docking analysis was done 12In diabetic rats given Streptozotocin (STZ) and a high-fat diet (HFD), the study examines the synthesis, characterization, and assessment of a zinc-morin complex. The complex's oral administration significantly improved insulin resistance, glucose intolerance, hyperglycemia, and antioxidant competence, according to the results. According to the study's findings, the complex may have antioxidant, antidyslipidemic, and antidiabetic effects. 13 

Anti-cancer activity: The study investigates the ability to prevent cancer by mulberry flavonoid morin, which upregulates the Fas receptor and causes HCT-116 cells to produce caspase-8, -9, and -3. Morin turns on bid as well, and induces mitochondrial membrane potential loss. It also causes the production of ROS and suppresses anti-apoptotic proteins, such as Bcl-2 and cIAP-1. The study suggests that the crucial upstream signaling is Akt, regulating morin's apoptotic process. 14 Morin has anticancer properties, and was found to prevent the potential for breast cancer cells in humans to spread when endothelial growth factor is present. It inhibited the EGFR signaling pathway, which in turn suppressed MMP-9 activity and cell migration, causing DNA damage, and activating autophagy. Morin could be a potential therapeutic candidate for HER2 overexpressing breast cancer. 15

In male Wistar rats, morin's protective effect on the liver against ethanol-induced biochemical alterations was assessed. After 60 days of ethanol use, oxidative stress increased and antioxidant levels decreased, resulting in liver and kidney damage. Morin may lessen alcohol-induced liver damage because it decreases the breakdown of lipids as well as repairs antioxidant, hepatic, along renal markers when taken orally 16

Hepatoprotection: Three flavonoids—quercetin, silybin, and morin—are tested for their ability to shield mice from microcystin toxicity. Results show that these flavonoids can reverse the MC-LR's hepatotoxic effects in vivo, with no significant changes in serum alanine aminotransferase, catalase activity, or protein phosphatase activity 17

Neuroprotection: Morin investigates the protective properties of natural flavonoid morin against arsenic and cadmium-induced neurotoxicity in PC12 cells. Results show that morin increases cell viability, decreases reactive oxygen species production, and reduces cleaved-caspase-3 levels, making it a promising treatment for these toxic metals 18.  A study on morin's preclinical bio-efficacy on focal ischemia in animals showed positive effects, including reduced neurological deficits, reduced MDA content, and increased antioxidant levels. Morin's neuroprotective effects may aid in ischemic stroke amelioration 19

One study has discovered that a diet containing morin can safeguard against oxidative stress and neuroinflammation in PD-induced mice. The diet-maintained motor function against dysfunction and improved dopaminergic neuronal injury of the striatum and substantia nigra. Neuroinflammation was also minimized by morin, down-regulating glial activations of microglia and astrocytes. This has indicated that morin may act as a functional food component that can treat neurodegenerative diseases such as PD and other neurodegenerative disorders connected with neuroinflammation 20

Cardio protection: The impact of natural flavanol morin on isolated heart tissue from rats and cardiac cells' myocardial ischemia-reperfusion injury (MIRI). The results indicate that morin treatment improves cardiac function, reduces infarct size, increases cell viability, and lowers LDH activity. Nevertheless, atractyloside treatment reverses these effects. 21

Anti-Bacterial Activity: According to a study, the bioavailable flavonoid morin exhibits antibacterial properties against Vibrio cholerae. The bacterial divisome protein, VcFtsA, is bound by morin, which prevents its polymerization and ATPase activity. V. cholerae's cell division is impacted by this interaction, resulting in an elongated shape. Morin's low cytotoxicity to human cells makes it a useful therapeutic agent. This research may aid in the synthesis of new derivatives that more effectively target VcFtsA 22

Antimicrobial Activity: A commonly occurring fungal infection, Candida albicans is made more pathogenic by virulence factors. Morin, a photo-bioactive compound, has been shown in a study to have strong inhibitory potential against virulence factors and biofilm formation. Morin has the potential to be a powerful therapeutic drug by successfully rescuing animals from candida infection and increasing their survival rate, according to in vivo studies conducted on zebrafish. 23

Antiviral Activity:  Dengue hemorrhagic fever is a severe disease caused by a dengue infection (DHF). Guava has been demonstrated to increase thrombocyte counts in patients due to its high tannin content and flavonoids, including guajavarin, quercetin, and morin. In order to determine how the morin compound impacted dengue virus replication, this study used the Viral ToxGlo assay. The Vero cell lines' CC50 was 12.46 µg/ml, whereas the dengue virus compounds' IC50 value was 9.42 µg/ml. 24

Synergetic Activity

Antiviral & Anti-inflammatory effect: The research investigated the potential of morin hydrate, a flavonoid derived from Morus alba L., to combat the influenza A/Puerto Rico/8/1934 (A/PR/8; H1N1) virus, as well as a strain of the virus that has developed resistance to oseltamivir. According to the results, morin hydrate reduces chemokines and pro-inflammatory cytokines in infected mice, relieves symptoms, and lessens hemagglutination by A/PR/8. Co-administration of oseltamivir phosphate and morin hydrate reduces pulmonary inflammation and virus titers, suggesting antiviral activity. 25

Anti-inflammatory & Neuroprotective: According to one study, in a mouse model of Parkinson's disease, a diet high in morin reduces dopaminergic neuronal damage and prevents motor dysfunction. By blocking the ERK–p65 pathway, morin inhibits glial activations, suggesting that it may have therapeutic value in the management of neurodegenerative diseases like Parkinson's disease. 26


 

 

SUMMARY

Pharmacological Activity

Disease/Model Used

Experimental Outcome / Mechanism

References

Anti-inflammatory

 

TNBS-induced colitis in rats

↓ NOS, ↑ tissue repair, ↓ MPO activity

Gálvez et al., 2001

 

PD-induced mice

↓ glial activation, ↓ ERK–p65 pathway

Hong et al., 2022

Anti- Oxidant

 

ABTS•+ and H₂O₂-induced damage

↑ Nrf2/HO-1, ↓ ROS, ↓ DNA damage, ↑ viability

Lee et al., 2017

ISO-treated rats

↓ TBARS, ↑ antioxidant enzymes

Al-Numair et al., 2014

Antidiabetic

HepG2 cells, docking study

PTP1B inhibition, insulin sensitization

Paoli et al., 2013

STZ + HFD rats (Zinc-morin complex)

↓ glucose, ↑ insulin sensitivity, ↑ antioxidant potential

Sendrayaperumal & Devaraj, 2010

Anti-Cancer

HCT-116 colon cancer cells

↑ Fas, caspase-8, -9, -3; ↓ Bcl-2, ↑ ROS

Hyun et al., 2015

HER2+ breast cancer cells

↓ EGFR, ↓ MMP-9, ↑ DNA damage, autophagy activation

Lee et al., 2021

Hepatoprotective

Ethanol-treated Wistar rats

↓ lipid breakdown, ↑ hepatic & renal markers

Shankari et al., 2010

Microcystin-LR exposure in mice

↓ ALT, normalized catalase and phosphatase activity

Jayaraj et al., 2007

Neuroprotective

PC12 cells (arsenic/cadmium neurotoxicity)

↓ ROS, ↑ viability, ↓ caspase-3

Banaeeyeh et al., 2024

PD-induced mice

↓ neuroinflammation, ↑ dopaminergic neuron survival

Hong et al., 2022

Ischemia model in animals

↓ MDA, ↓ deficits, ↑ antioxidant levels

Chen et al., 2017

Cardioprotective

Myocardial I/R injury in isolated rat hearts

↑ cell viability, ↓ infarct size, improved function

Liu et al., 2018

 


 

FUTURE ASPECTS

According to the various studies this article reviews, Morin Hydrate has proven helpful in the treatment of a variety of human illnesses. Even though in vitro and in vivo research has attempted to clarify the mechanisms of Morin Hydrate, more research is necessary to explain its molecular mechanism. Furthermore, clinical investigations are desperately needed to establish their potential utility of Morin.

Acknowledgement: This review paper was prepared by Sampda Jain and Yogesh Yadav under the supervision of Professor Manoj Sharma. The authors express their sincere gratitude to Professor Manoj Sharma for his constant guidance, encouragement, and insightful feedback throughout the preparation of this manuscript. The authors would also like to thank Jiwaji University, Gwalior, Madhya Pradesh, India for providing institutional support. This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sector

Conflict of Interest: The authors, Sampda Jain and Yogesh Yadav, declare that they have no known financial or personal relationships that could have appeared to influence the work reported in this paper. The research was conducted independently under the academic supervision of Prof. Manoj Sharma. All potential conflicts of interest have been disclosed.

Author Contributions: Sampda Jain and Yogesh Yadav conceptualized the review and designed its framework. Sampda Jain conducted the literature search and drafted the manuscript. Yogesh Yadav contributed to critical analysis of the literature and manuscript refinement. Prof. Manoj Sharma supervised the work and provided intellectual guidance and critical revisions. All authors read and approved the final version of the manuscript and agreed to be accountable for all aspects of the work.

Source of Support: Nil

Funding: The authors declared that this study has received no financial support.

Informed Consent Statement: This study complies with ethical standards concerning human data usage. If any identifiable information or case-specific details are included, written informed consent was obtained from the individuals involved. The type of consent (written, verbal, or electronic) has been documented and is available upon request, in accordance with the policies of the institutional ethical review board. The authors affirm that patient confidentiality has been maintained throughout the study.

Data Availability Statement: The data supporting this paper are available in the cited references. 

Ethical approval: Not applicable.

REFERENCES

1. Sinha K, Ghosh J, Sil PC. Morin and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016;928:453-471. https://doi.org/10.1007/978-3-319-41334-1_19 PMid:27671828

2. Caselli A, Cirri P, Santi A, Paoli P. Morin: A promising natural drug. Curr Med Chem. 2016;23(8):774-791. https://doi.org/10.2174/0929867323666160106150821 PMid:26018232

3. Ullah A, Munir S, Badshah SL, et al. Important flavonoids and their role as a therapeutic agent. Molecules. 2020;25(22):5243. https://doi.org/10.3390/molecules25225243 PMid:33187049 PMCid:PMC7697716

4. Mendoza-Wilson AM, Santacruz-Ortega H, Balandrán-Quintana RR. Relationship between structure, properties, and the radical scavenging activity of morin. J Mol Struct. 2011;995(1-3). https://doi.org/10.1016/j.molstruc.2011.04.004

5. Solairaja S, Andrabi MQ, Dunna NR, Venkatabalasubramanian S. Overview of morin and its complementary role as an adjuvant for anticancer agents. Nutr Cancer. 2021;73(6):927-942. https://doi.org/10.1080/01635581.2020.1778747 PMid:32530303

6. National Center for Biotechnology Information. PubChem Compound Summary for CID 5281670, Morin. Accessed April 16, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/Morin 

7. Sinha K, Ghosh J, Sil PC. Morin and its role in chronic diseases. In: Adv Exp Med Biol. 2016;928:453-471. https://doi.org/10.1007/978-3-319-41334-1_19 PMid:27671828

8. Kataria R, Khatkar A. Molecular docking, synthesis, kinetics study, structure-activity relationship and ADMET analysis of morin analogous as Helicobacter pylori urease inhibitors. BMC Chem. 2019;13(1):45. https://doi.org/10.1186/s13065-019-0562-2 PMid:31384793 PMCid:PMC6661831

9. Gálvez J, Coelho G, Crespo ME, et al. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment Pharmacol Ther. 2001;15(12). https://doi.org/10.1046/j.1365-2036.2001.01133.x PMid:11736735

10. Lee MH, Cha HJ, Choi EO, et al. Antioxidant and cytoprotective effects of morin against hydrogen peroxide-induced oxidative stress are associated with the induction of Nrf-2 mediated HO-1 expression in V79-4 Chinese hamster lung fibroblasts. Int J Mol Med. 2017;39(3):672-680. https://doi.org/10.3892/ijmm.2017.2871 PMid:28204816

11. Al-Numair KS, Chandramohan G, Alsaif MA, Veeramani C, El Newehy AS. Morin, a flavonoid, on lipid peroxidation and antioxidant status in experimental myocardial ischemic rats. Afr J Tradit Complement Altern Med. 2014;11(3):14-20. https://doi.org/10.4314/ajtcam.v11i3.3 PMid:25371558 PMCid:PMC4202414

12. Paoli P, Cirri P, Caselli A, et al. The insulin-mimetic effect of morin: a promising molecule in diabetes treatment. Biochim Biophys Acta. 2013;1830(4):3102-3111. https://doi.org/10.1016/j.bbagen.2013.01.017 PMid:23352912

13. Sendrayaperumal V, Iyyam Pillai S, Subramanian SP. Design, synthesis and characterization of zinc-morin, a metal flavonol complex and evaluation of its antidiabetic potential in HFD-STZ induced type 2 diabetes in rats. Chem Biol Interact. 2014;219:9-17. https://doi.org/10.1016/j.cbi.2014.05.003 PMid:24854284

14. Hyun H, Lee WS, Go S, et al. The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells. Int J Oncol. 2015;46:2670-2678. https://doi.org/10.3892/ijo.2015.2967 PMid:25892545

15. Lee KS, Lee MG, Nam KS. Evaluation of the antimetastatic and anticancer activities of morin in HER2 overexpressing breast cancer SK BR 3 cells. Oncol Rep. 2021;46(1):126. https://doi.org/10.3892/or.2021.8077 PMid:33982761

16. Shankari SG, Karthikesan K, Jalaludeen AM, Ashokkumar N. Hepatoprotective effect of morin on ethanol-induced hepatotoxicity in rats. J Basic Clin Physiol Pharmacol. 2010;21(4):277-294. https://doi.org/10.1515/JBCPP.2010.21.4.277 PMid:21305846

17. Jayaraj R, Deb U, Bhaskar AS, Prasad GB, Rao PV. Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in mice. Environ Toxicol. 2007;22(5):472-479. https://doi.org/10.1002/tox.20283 PMid:17696131

18. Banaeeyeh S, Razavi BM, Hosseinzadeh H. Neuroprotective effects of morin against cadmium- and arsenic-induced cell damage in PC12 neurons. Biol Trace Elem Res. 2024. https://doi.org/10.1007/s12011-024-04407-x PMid:39436547

19. Chen Y, Li Y, Xu H, et al. Morin mitigates oxidative stress, apoptosis and inflammation in cerebral ischemic rats. Afr J Tradit Complement Altern Med. 2017;14(2):348-355. https://doi.org/10.21010/ajtcam.v14i2.36 PMid:28573251 PMCid:PMC5446461

20. Hong DG, Lee S, Kim J, et al. Anti-inflammatory and neuroprotective effects of morin in an MPTP-induced Parkinson's disease model. Int J Mol Sci. 2022;23(18):10578. https://doi.org/10.3390/ijms231810578 PMid:36142491 PMCid:PMC9501291

21. Liu S, Wu N, Miao J, et al. Protective effect of morin on myocardial ischemia reperfusion injury in rats. Int J Mol Med. 2018;42(3):1379-1390. https://doi.org/10.3892/ijmm.2018.3743

22. Nag D, Dastidar DG, Chakrabarti G. Natural flavonoid morin showed anti-bacterial activity against Vibrio cholera after binding with cell division protein FtsA near ATP binding site. Biochim Biophys Acta Gen Subj. 2021;1865(8):129931. https://doi.org/10.1016/j.bbagen.2021.129931 PMid:34023444

23. Abirami G, Alexpandi R, Durgadevi R, et al. Inhibitory effect of morin against Candida albicans pathogenicity and virulence factor production: an in vitro and in vivo approaches. Front Microbiol. 2020;11:561298. https://doi.org/10.3389/fmicb.2020.561298 PMid:33193145 PMCid:PMC7644646

24. Maharani A, Sucipto TH, Setyawati H, et al. In vitro antiviral activity of morin compound against dengue virus type 1 in Vero cells. Syst Rev Pharm. 2020;11(9):830-833. https://doi.org/10.31838/srp.2020.9.118 

25. Hong EH, Song JH, Kim SR, et al. Morin hydrate inhibits influenza virus entry into host cells and has anti-inflammatory effect in influenza-infected mice. Immune Netw. 2020;20(4):e32. https://doi.org/10.4110/in.2020.20.e32 PMid:32895619 PMCid:PMC7458794

26. Hong DG, Lee S, Kim J, et al. Anti-inflammatory and neuroprotective effects of morin in an MPTP-induced Parkinson's disease model. Int J Mol Sci. 2022;23(18):10578. https://doi.org/10.3390/ijms231810578 PMid:36142491 PMCid:PMC9501291

27. Arriagada F, Correa O, Günther G, et al. Morin flavonoid adsorbed on mesoporous silica, a novel antioxidant nanomaterial. PLoS One. 2016;11(11):e0164507. https://doi.org/10.1371/journal.pone.0164507 PMid:27812111 PMCid:PMC5094702